Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ropivacaine + Methylene Blue for Analgesia in Hip Arthroplasty
NCT06284941Completed
- Start
- Jun 2023
- Primary completion
- Feb 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of methylene blue in postoperative pain (2 arms). Primary endpoint: Visual Analogue Scale at 48 hours. Started Jun 2023; status: completed.
02
Drugs
methylene blue
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT06284941.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06284941.